Unknown

Dataset Information

0

Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1.

ABSTRACT: We analyzed single nucleotide polymorphisms (SNPs) in PKNOX1 (rs2839629) and in the intergenic region between PKNOX1 and CBS (rs915854) by Sanger sequencing in 88 patients with multiple myeloma treated with bortezomib. All patients (n = 13) harboring a homozygous mutation in PKNOX1 (rs2839629) also had a homozygous mutated rs915854 genotype. Homozygous mutated genotypes of rs2839629 and rs915854 were significantly enriched in patients with painful peripheral neuropathy (PNP) (P < 0.0001), and homozygous mutated rs2839629 genotype was significantly enriched in patients with pain compared to patients with no pain (P = 0.04). In summary, both SNPs rs2839629 and/or rs915854 may be potential biomarkers predicting an increased risk to develop painful PNP under bortezomib.

SUBMITTER: Zhou X 

PROVIDER: S-EPMC10189922 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

We analyzed single nucleotide polymorphisms (SNPs) in PKNOX1 (rs2839629) and in the intergenic region between PKNOX1 and CBS (rs915854) by Sanger sequencing in 88 patients with multiple myeloma treated with bortezomib. All patients (n = 13) harboring a homozygous mutation in PKNOX1 (rs2839629) also had a homozygous mutated rs915854 genotype. Homozygous mutated genotypes of rs2839629 and rs915854 were significantly enriched in patients with painful peripheral neuropathy (PNP) (P < 0.0001), and ho  ...[more]

Similar Datasets

Unknown Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy.
| S-EPMC7830235 | biostudies-literature
Unknown Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain.
| S-EPMC6247555 | biostudies-literature
Unknown Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy.
| S-EPMC7848563 | biostudies-literature
Clinical Exploratory research to investigate the single nucleotide polymorphisms (SNP) which can predict oxaliplatin-induced neuropathy
| 2616724 | ecrin-mdr-crc
Unknown Specific Attenuation of Purinergic Signaling during Bortezomib-Induced Peripheral Neuropathy In Vitro.
| S-EPMC8998302 | biostudies-literature
Unknown Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study.
| S-EPMC4038108 | biostudies-literature
Unknown Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.
| S-EPMC7161266 | biostudies-literature
Unknown Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients.
| S-EPMC3208695 | biostudies-literature
Unknown Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.
| S-EPMC2717758 | biostudies-literature
Unknown Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients.
| S-EPMC3816208 | biostudies-literature